Clinical Trials Browser

Phase 2 × Uterine Neoplasms × camrelizumab × Clear all

NCT04239443 2020-01-27

Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer

Phase 2 Unknown

GynecologicSarcoma

Sarcoma, Uterine Neoplasms